|
Neose, BioGeneriX Enter Protein Pact
Neose Technologies has signed an agreement giving BioGeneriX AG an option to license its GlycoPEGylation technology. The total potential value of the deal wasn't disclosed in a press release by Neose. The biopharmaceutical company did say, however, that it includes milestones worth up to $61.5 million and unspecified upfront payments and royalties. The agreement aims to use the Neose technology to develop a "long-acting, next generation version of a currently marketed therapeutic protein," according to Neose. iWon |
Register Now
Archives